BioNTech said on Monday that its order backlog together with partner Pfizer for delivery of COVID-19 vaccines this year had grown to 1.8 billion doses, underscoring its role as a major global supplier of immunization shots. That was up from 1.4 billion doses announced in March.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook